Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Engineered Salmonella secreting heterologous bacterial flagellin suppress tumor growth by activating intratumoral macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with intratumoral or intravenous injection often leading to ~10,000-fold accumulation in tumors relative to matched liver, spleen, and lung tissues (152, 153).”
From The microbiome and human cancer (2021) · cites this paper as [152]
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“INTRODUCTION Abnormal blood vessels and hypoxic and necrotic regions are universal features of solid tumors (1, 2).”
BackgroundKigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130 · cited 1×
“The engrafted MC38 tumor tissues were removed from C57BL/6 WT mice 24 hours after induction of FlaB and triple-stained with CD45, F4/80, and CD206 (to detect M2-type macrophages) or with CD45, F4/80, and CD86 (to detect M1-type macrophages) (32, 33).”
MethodTargeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 1×
“TLR4, TLR5, and MyD88 knockout mice with a C57BL/6 genetic background were described previously (47, 48).”
MethodMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980 · cited 10×
“The in vitro stimulation of cancer cells with FlaB did not increase phosphorylation of NF-kB p65 (fig.”
BackgroundInfluentialThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“Cell preparation and FACS analysis Peritoneal macrophages were isolated from specific pathogen–free C57BL/6 male mice, as described previously (50).”
MethodToll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871 · cited 1×
“Because the background signals in experimental groupswere different, whichmay be due to different degrees of cell injury resulting from the different modes of treatment (PBS, empty Salmonella, and FlaB-secreting Salmonella), we adjusted gating parameters for the FACS analysis of different groups (51, 52).”
MethodTherapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 1×
“Because of accumulating reports that activating various TLRs resulted in antitumor effects (31, 37–41), many TLRspecific agonists are currently being investigated for tumor immunotherapy (37).”
BackgroundBiswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“VNP20009, an attenuated strainof Salmonella typhimurium with purI and msbB gene deletions, was safely administered to patients with metastatic melanoma and renal cell carcinoma in a phase 1 study, where substantial tumor colonization was observed (11, 12).”
Research works printed but not linked: 1
- 10.1200/jco.2002.20.1.142 · DOI · Paper page
Cited by
Items 101–200 of 627
Li, W.-Q., Wang, Z., Hao, S., Sun, L., Nisic, M., Cheng, G., Zhu, C., Wan, Y., Ha, L., & Zheng, S.-Y. (2018) · Nanoscale · doi:10.1039/c7nr08816g · Cited by 80
Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics
Qiao, L., Niu, L., Wang, Z., Deng, Z., Di, D., Ma, X., Zhou, Y., Kong, D., Wang, Q., Yin, J., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00932-3 · Cited by 80
“…bacteria, several remote-control systems have been developed to regulate transgene expression of engineered bacteria triggered by chemical inducers 8 and Article https://doi.org/10.1038/s43018-025-00932-3 allowing the transcriptional activator MrkH to bind to its chimeric promoter P mrkA and…”
InfluentialReprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella
Nguyen, D.-H., You, S.-H., Ngo, H. T.-T., Nguyen, K. V., Tran, K. V., Chu, T.-H., Kim, S.-Y., Ha, S., Hong, Y., & Min, J. (2024) · Nature Communications · doi:10.1038/s41467-024-50950-5 · Cited by 78
Self-citationMicrobes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment
Sawant, S. S., Patil, S. M., Gupta, V., & Kunda, N. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207575 · Cited by 78
“Salmonella relA- and spoT-mutant strains were altered causing malfunctioning in the synthesis of ppGpp, a signaling molecule involved in expression of toxic genes and thereby, improving the safety [2,52].”
BackgroundBacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer
Coleman, O. I., & Haller, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01927 · Cited by 77
“A recent study applied an approach to cancer immunotherapy through the use of an attenuated Salmonella typhimurium strain engineered to secrete Vibrio vulnificus Flagellin B (FlaB) (154).”
BackgroundEngineered microbial systems for advanced drug delivery
Shen, H., Aggarwal, N., Wun, K. S., Lee, Y. S., Hwang, I. Y., & Chang, M. W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114364 · Cited by 76
Microbe-based therapies for colorectal cancer: Advantages and limitations
Saeed, M., Shoaib, A., Kandimalla, R., Javed, S., Almatroudi, A., Gupta, R. C., & Aqil, F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.018 · Cited by 74
Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy
Chen, W., Zhu, Y., Zhang, Z., & Sun, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114295 · Cited by 68
Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
Jiang, J., Mei, J., Yi, S., Feng, C., Ma, Y., Liu, Y., Liu, Y., & Chen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114046 · Cited by 72
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics
Chen, Y., Liu, X., Guo, Y., Wang, J., Zhang, D., Yang, M. J., Shi, J., Tan, W., & Zheng, J. H. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.006 · Cited by 71
Self-citationUse of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches
Badie, F., Ghandali, M., Tabatabaei, S. A., Safari, M., Khorshidi, A., Shayestehpour, M., Mahjoubin‐Tehran, M., Morshedi, K., Jalili, A., Tajiknia, V., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.624759 · Cited by 71
“es and suppression ofM2 TLR4 and MyD88 knockout mice (TLR5)-negative (114)”
BackgroundFelgner, S., Kocijancic, D., Frahm, M., Heise, U., Rohde, M., Zimmermann, K., Falk, C. S., Erhardt, M., & Weiß, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1382791 · Cited by 70
“other important Salmonella strains in the field of BMTT like A1-R(43-49) or the recently described and optimized ppGpp mutant.(40,50)”
BackgroundLarge-scale recoding of a bacterial genome by iterative recombineering of synthetic DNA
Lau, Y. H., Stirling, F., Kuo, J., Karrenbelt, M. A. P., Chan, Y. A., Riesselman, A. J., Horton, C. A., Schäfer, E., Lips, D., Weinstock, M. T., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx415 · Cited by 69
Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses
Chen, W., He, C., Qiao, N., Guo, Z., Hu, S., Song, Y., Wang, H., Zhang, Z., Ke, B., & Sun, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121582 · Cited by 68
Wu, L., Li, L., Li, S., Liu, L., Xin, W., Li, C., Yin, X., Xu, X., Bao, F., & Hua, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.006 · Cited by 68
Lauté-Caly, D. L., Raftis, E. J., Cowie, P., Hennessy, E., Holt, A., Panzica, D. A., Sparre, C., Minter, B., Stroobach, E., & Mulder, I. E. (2019) · Scientific Reports · doi:10.1038/s41598-018-36926-8 · Cited by 67
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
Allemailem, K. S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s338272 · Cited by 67
“In the presence of tumor environment, these bacteria proliferate and trigger necrosis, apoptosis, and cell rupture, thus kill the surrounding cancer cells.(14) The cancer cells are forced to produce gap junction protein (connexin 43) by Salmonella spp.”
Yang, S., Sheffer, M., Kaplan, I. E., Wang, Z., Tarannum, M., Dinh, K., Abdulhamid, Y., Bobilev, E., Shapiro, R., Porter, R., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02418-6 · Cited by 66
Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
Yang, Y., Li, H., Fotopoulou, C., Cunnea, P., & Zhao, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049340 · Cited by 66
“inactivated virus (67), engineered bacteria (175), and modified T cells (97)).”
BackgroundDual functional roles of the MyD88 signaling in colorectal cancer development
Wang, L., Yu, K., Zhang, X., & Yu, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.139 · Cited by 66
Biosensing in Smart Engineered Probiotics
Rottinghaus, A. G., Amrofell, M. B., & Moon, T. S. (2020) · Biotechnology Journal · doi:10.1002/biot.201900319 · Cited by 67
Engineered live bacteria as disease detection and diagnosis tools
Tanniche, I., & Behkam, B. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00379-z · Cited by 65
Synthetic Biology Approaches in the Development of Engineered Therapeutic Microbes
Kang, M., Choe, D., Kim, K., Cho, B., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228744 · Cited by 64
“In tumor-bearing mice, the presence of flagellin activates the toll-like receptor 5 (TLR5) signaling pathway to induce an immune response against tumor growth [69].”
BackgroundBacteria-Inspired Nanomedicine
Holay, M., Guo, Z., Pihl, J., Heo, J., Park, J. H., Fang, R. H., & Zhang, L. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01072 · Cited by 64
Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
Noci, V. L., Bernardo, G., Bianchi, F., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732192 · Cited by 63
Programming the lifestyles of engineered bacteria for cancer therapy
Fu, S., Zhang, R., Gao, Y., Xiong, J., Li, Y., Pu, L., Xia, A., & Jin, F. (2023) · National Science Review · doi:10.1093/nsr/nwad031 · Cited by 64
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy
Ijaz, M., Hasan, I., Chaudhry, T. H., Huang, R., Zhang, L., Hu, Z., Tan, Q., & Guo, B. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02786-w · Cited by 63
“…[163] Escherichia coli CD47 nanobodies Genetic modification Immunotherapy [21] Salmonella typhimurium FlaB Genetic modification Immunotherapy [175] Salmonella typhimurium NY-ESO-1 Genetic modification Immunotherapy [176] Salmonella typhimurium Cytolysin A Genetic modification Protein-based…”
BackgroundTumor microbiome: roles in tumor initiation, progression, and therapy
Zhang, S., Huang, J., Jiang, Z., Tong, H., Ma, X., & Liu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00248-9 · Cited by 63
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
The intratumoral microbiome: Characterization methods and functional impact
Heymann, C. J. F., Bard, J.-M., Heymann, M.-F., Heymann, D., & Bobin-Dubigeon, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.009 · Cited by 57
ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models
Kim, J.-S., Park, J.-E., Choi, S.-H., Kang, S. W., Lee, J. H., Lee, J.-S., Shin, M., & Park, S.-H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.001 · Cited by 61
Self-citationFan, J., Liu, X., Wang, X., Niu, M., Chen, Q., Zheng, D., Wei, J., Yang, X., Zeng, X., & Zhang, X. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009744 · Cited by 61
Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Liu, Y., Niu, L., Li, N., Wang, Y., Liu, M., Su, X., Bao, X., Yin, B., & Shen, S. (2023) · Advanced Science · doi:10.1002/advs.202205641 · Cited by 60
Imaging of tumor colonization by Escherichia coli using 18F-FDS PET
Kang, S., Jo, E. J., Nguyen, V. H., Zhang, Y., Yoon, H. S., Pyo, A., Kim, D.-Y., Hong, Y., Bom, H., & Min, J. (2020) · Theranostics · doi:10.7150/thno.42121 · Cited by 60
“These results are consistent with previous reports showing that the number of tumor-targeting bacteria is initially high in the liver and then decreases drastically at 3 to 4 dpi [27, 28].”
ResultSelf-citationHarnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jiang, J., Huang, Y., Zeng, Z., & Zhao, C. (2023) · ACS Nano · doi:10.1021/acsnano.2c07607 · Cited by 59
Chen, W., Song, Y., Bai, S., He, C., Guo, Z., Zhu, Y., Zhang, Z., & Sun, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c00363 · Cited by 60
Sonogenetics-controlled synthetic designer cells for cancer therapy in tumor mouse models
Gao, T., Niu, L., Wu, X., Dai, D., Zhou, Y., Liu, M., Wu, K., Yu, Y., Guan, N., & Ye, H. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101513 · Cited by 59
Hwang, H. S., Cherukula, K., Bang, Y. J., Vijayan, V., Moon, M. J., Thiruppathi, J., Puth, S., Jeong, Y. Y., Park, I., Lee, S. E., et al. (2020) · Cells · doi:10.3390/cells9112432 · Cited by 59
“In our previous studies, we have shown that the TLR5 agonist flagellin served as an excellent adjuvant inducing effective cell-mediated immunity (CMI) against coadministered TAA peptide epitopes [22,23] and flagellin-secreting bacteria modulated TME to induce effective antitumor immune response [24].”
BackgroundSelf-citationHypoxic Tumor Radiosensitization Using Engineered Probiotics
Huang, C., Wang, X., Liu, L., Jiang, W., Liu, W., Ma, W., & Zhao, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002207 · Cited by 59
Engineered bacteria as drug delivery vehicles: Principles and prospects
Zhou, Y., & Han, Y. C. (2022) · Engineering Microbiology · doi:10.1016/j.engmic.2022.100034 · Cited by 56
Xia, L., Zhu, X., Wang, Y., & Lü, S. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217123 · Cited by 56
The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Hekmatshoar, Y., Saadat, Y. R., Khatibi, S. M. H., Özkan, T., Vahed, F. Z., Nariman‐Saleh‐Fam, Z., Gargari, B. P., Sunguroğlu, A., & Vahed, S. Z. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116680 · Cited by 56
Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models
Liang, K., Liu, Q., Li, P., Han, Y., Bian, X., Tang, Y., & Kong, Q. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0021-6 · Cited by 55
Ahmed, S., Oliva, G., Shao, M., Wang, X., Mekalanos, J. J., & Brenner, G. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202719119 · Cited by 54
“Furthermore, bacterial injection of tumors inhibits angiogenesis (14), shifts tumoral macrophages from M2 (tumor promoting) to M1 (tumoricidal) types (11, 15), and induces antitumor adaptive immunity (16).”
BackgroundBacteria-based bioactive materials for cancer imaging and therapy
Chen, Y., Li, Z.-H., Zeng, X., & Zhang, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114696 · Cited by 54
Leveraging macrophages for cancer theranostics
Liu, L., Li, H., Wang, J., Zhang, J., Liang, X., Guo, W., & Gu, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114136 · Cited by 54
In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools
Antonelli, A. C. B., Almeida, V. P., de Castro, F. D. O. F., Silva, J. M., Pfrimer, I. A. H., Cunha‐Neto, E., Maranhão, A. Q., Brígido, M. M., Resende, R. O., Bocca, A. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-03990-6 · Cited by 53
Potential Application of Living Microorganisms in the Detoxification of Heavy Metals
Chen, R., Tu, H., & Chen, T. (2022) · Foods · doi:10.3390/foods11131905 · Cited by 53
“To date, recombinant bacteria have been used in attempts for the treatment of metabolic disorders such as diabetes [31], phenylketonuria (PKU) [32], autoimmune diseases such as inflammatory bowel disease [33], and cancer [34].”
Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
Hernández-Luna, M. A., & Luría-Pérez, R. (2018) · Journal of Immunology Research · doi:10.1155/2018/2984247 · Cited by 53
Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
Wang, G., He, X., & Wang, Q. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188846 · Cited by 52
Wu, Y., Liu, B., Yan, Y., Gong, C., Wang, K., Liu, N., Zhu, Y., Li, M., Wang, C., Yang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54883-x · Cited by 52
“Regarding your first question, in fact, there have been relevant studies on tumor colonization of Salmonella, and our results are consistent with them 17, 18 .”
Chemotactic Micro/Nanomotors for Biomedical Applications
Xia, X., Li, Y., Xiao, X., Zhang, Z.-Q., Mao, C., Li, T., & Wan, M. (2023) · Small · doi:10.1002/smll.202306191 · Cited by 51
Nanobiohybrids: A Synergistic Integration of Bacteria and Nanomaterials in Cancer Therapy
Chen, Y., Du, M., Yu, J., Rao, L., Chen, X. S., & Chen, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0008 · Cited by 51
Background-suppressed tumor-targeted photoacoustic imaging using bacterial carriers
Gao, R., Liu, F., Liu, W., Zeng, S., Chen, J., Gao, R., Wang, L., Fang, C., Song, L., Sedgwick, A. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121982119 · Cited by 51
Advances of bacteria-based delivery systems for modulating tumor microenvironment
Li, S., Yue, H., Wang, S., Li, X., Wang, X., Guo, P., Ma, G., & Wei, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114444 · Cited by 51
David, F., Davis, A. M., Gossing, M., Hayes, M. A., Romero, E., Scott, L. H., & Wigglesworth, M. J. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211000669 · Cited by 50
Pangilinan, C. R., & Lee, C.-H. (2019) · Biomedicines · doi:10.3390/biomedicines7020036 · Cited by 44
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases
Meng, J., Liu, S., & Wu, X. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2190392 · Cited by 49
“For example, there are studies to develop engineered bacteria that target cancer diseases by designing attenuated S. Typhimurium (Zheng et al. 2017).”
BackgroundHypoxia-targeting bacteria in cancer therapy
Staedtke, V., Sun, N., & Bai, R.-Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.03.003 · Cited by 48
Fu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
“Zheng et al. 274 engineered an attenuated Salmonella typhimurium (S. typhimurium) strain to overexpress and secrete a heterologous bacterial Vibrio vulnificus flagellin B (FlaB), which acted as an admirable immunotherapy adjuvant through activating innate immune responses via TLR5 pathway.”
BackgroundSelf-citationBacteria-based immune therapies for cancer treatment
Howell, L. M., & Forbes, N. S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.006 · Cited by 48
Boesch, M., Horvath, L., Baty, F., Pircher, A., Wolf, D., Spahn, S., Straussman, R., Tilg, H., & Brutsche, M. H. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005401 · Cited by 38
Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics
Li, X., Gao, Y., Li, H., Majoral, J., Shi, X., & Pich, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101170 · Cited by 48
Zhang, Y., Tan, W., Sultonova, R. D., Nguyen, D.-H., Zheng, J. H., You, S.-H., Rhee, J. H., Kim, S.-Y., Khim, K., Hong, Y., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122135 · Cited by 47
Self-citationSu, P., Li, O., Ke, K., Jiang, Z., Wu, J., Wang, Y., Mou, Y., & Jin, W. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5648 · Cited by 47
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
Grau, M., Walker, P. R., & Derouazi, M. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2785-0 · Cited by 47
“In a similar manner, injection of an engineered Salmonella typhimurium strain secreting Vibrio vulnificus flagellin B in MC38 tumor bearing mice induced a strong anti-tumor effect, in part through the reprogramming of tumor-associated macrophages to an M1-antitumoral phenotype [67].”
Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues
Chu, B., Yang, Y., Tang, J., Song, B., He, Y., & Wang, H. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202208422 · Cited by 47
The application of bacteria-nanomaterial hybrids in antitumor therapy
Xiao, S., Mu, M., Feng, C., Pan, S., & Chen, N. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02793-x · Cited by 45
Wang, Y., Guo, W., Wu, X., Zhang, Y., Mannion, C. M., Brouchkov, A. V., Man, Y.-G., & Chen, T. (2019) · Journal of Cancer · doi:10.7150/jca.35648 · Cited by 46
“This process is achieved by initial colonization of the bacteria which recruits abuntdant immune cells including macrophages and neutrophils via TLR4 signalling pathway and further activation of these immune cells triggered by TLR5 signalling mediated by the secretion of FlaB [74], Other engineered S.”
BackgroundInfluentialYao, Y., Li, J., Li, P., Wang, D., Bao, W., Xiao, Y., Chen, X., He, S., Hu, J., & Yang, X. (2021) · Small · doi:10.1002/smll.202105716 · Cited by 45
Engineered bacteria in tumor immunotherapy
Chen, H., Zhu, Y., Zhang, C., Hu, L. T., & Yang, K. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216817 · Cited by 44
Rapid screening of engineered microbial therapies in a 3D multicellular model
Harimoto, T., Singer, Z. S., Velazquez, O. S., Zhang, J. T., Castro, S., Hinchliffe, T. E., Mather, W., & Danino, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820824116 · Cited by 44
Xie, S., Li, W., Liu, Y., Meng, J., Cao, W., Qiu, B., & Li, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.018 · Cited by 43
Tumour‐targeting bacteria‐based cancer therapies for increased specificity and improved outcome
Felgner, S., Pawar, V., Kocijancic, D., Erhardt, M., & Weiß, S. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12787 · Cited by 43
“expressing a secreted flagellin (Yun et al., 2012; Zheng et al., 2017), and SF200 which comprises several mutations affecting LPS and flagella synthesis, as well as containing metabolic modifications (unpublished data).”
BackgroundEngineered Attenuated Salmonella typhimurium Expressing Neoantigen Has Anticancer Effects
Hyun, J., Jun, S., Lim, H., Cho, H., You, S.-H., Ha, S., Min, J.-J., & Bang, D. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00097 · Cited by 43
Self-citationReprogramming Synthetic Cells for Targeted Cancer Therapy
Lim, B., Yin, Y., Ye, H., Cui, Z., Papachristodoulou, A., & Huang, W. E. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00631 · Cited by 43
Wen, M., Zheng, J. H., Choi, J. M., Pei, J., Li, C., Li, S., Kim, I., Lim, S.-H., Jung, T., Moon, K., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.031 · Cited by 42
Self-citationImplications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics
Dwivedi, M., Tiwari, S., Kemp, E. H., & Begum, R. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10450 · Cited by 42
“Overall, the gene expression data suggest that intra-tumoral Tregs with the same specificities are involved in different types of cancer [54,55].”
BackgroundWang, C., Chen, L., Zhu, J., Wang, C., Li, M., Yu, M., Liu, N., Ji, Z., Pan, F., Liu, Y., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202316092 · Cited by 41
Current Status and Future Directions of Bacteria-Based Immunotherapy
Tang, Q., Peng, X., Xu, B., Zhou, X., Chen, J., & Cheng, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911783 · Cited by 41
Engineering commensal bacteria to rewire host–microbiome interactions
Hwang, I. Y., & Chang, M. W. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.09.007 · Cited by 41
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Davar, D., & Zarour, H. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1129 · Cited by 40
“typhimurium demonstrate immunostimulatory potential (66, 67).”
Macandog, A. D. G., Catozzi, C., Capone, M., Nabinejad, A., Nanaware, P. P., Liu, S., Vinjamuri, S., Stunnenberg, J. A., Galiè, S., Jodice, M. G., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.006 · Cited by 40
Wang, L., Ji, P., Yu, J., Qiu, S., An, B., Huo, M., & Shi, J. (2024) · Science Advances · doi:10.1126/sciadv.adp7540 · Cited by 40
Design of nanorobots for exposing cancer cells
Dolev, S., Narayanan, R. P., & Rosenblit, M. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab1770 · Cited by 40
Integration of Salmonella into Combination Cancer Therapy
Al-Saafeen, B. H., Fernández-Cabezudo, M. J., & al-Ramadi, B. K. (2021) · Cancers · doi:10.3390/cancers13133228 · Cited by 40
“The enhanced recruitment of neutrophils following Salmonella administration was also documented [17,49,58,63], but it is still not clearly understood whether neutrophil infiltration promotes or inhibits tumor growth [64].”
BackgroundDeimmunization of flagellin for repeated administration as a vaccine adjuvant
Khim, K., Bang, Y. J., Puth, S., Choi, Y., Lee, Y. S., Jeong, K., Lee, S. E., & Rhee, J. H. (2021) · npj Vaccines · doi:10.1038/s41541-021-00379-4 · Cited by 40
“We also reported that FlaB-secreting Salmonella typhimurium effectively suppressed tumor growth and metastasis in mouse cancer models and prolonged survival through converting the tumor microenvironment towards tumor-suppressive condition [7].”
BackgroundSelf-citationStirling, F., & Silver, P. A. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.034 · Cited by 39
Perspectives on Immunotherapy of Metastatic Colorectal Cancer
Dai, Y., Zhao, W., Yue, L., Dai, X., Rong, D., Wu, F., Gu, J., & Qian, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.659964 · Cited by 39
Du, M., Wang, T., Peng, W., Feng, R., Goh, M., & Chen, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02437-0 · Cited by 38
Modular tuning engineering and versatile applications of genetically encoded biosensors
Zhang, J., Pang, Q., Wang, Q., Qi, Q., & Wang, Q. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1982858 · Cited by 38
Raman, V., Deshpande, C. P., Khanduja, S., Howell, L. M., Dessel, N. V., & Forbes, N. S. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.09.006 · Cited by 38
dos Reis, E. C., Leal, V. N. C., Soares, J. L. D. S., Fernandes, F. P., de Lima, D. S., de Alencar, B. C., & Pontillo, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01291 · Cited by 38
“Studies in mice show the stimulatory capacity of flagellin to induce both humoral and cellular immune responses when implied together with pathogen’ antigens as adjuvant (51, 52) or in cancer immunotherapy (53).”
BackgroundEngineered bacillus subtilis enhances bone regeneration via immunoregulation and anti-Infection
Fu, F.-S., Chen, H., Chen, Y., Yuan, Y., Zhao, Y. X., Yu, A., & Zhang, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.01.003 · Cited by 37
Self‐Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery
Zou, Z., Wang, X., Shi, X., Sun, S., Mi, J., Zhang, X. P., Yin, B., Zhou, Y. Q., & Ye, B. (2025) · Advanced Science · doi:10.1002/advs.202406486 · Cited by 37
Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products
Brittain, N. Y., & Finbloom, J. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115663 · Cited by 37
Photodynamic therapy-improved oncolytic bacterial immunotherapy with FAP-encoding S. typhimurium
Guo, Y., Song, M., Liu, X., Chen, Y., Xun, Z., Sun, Y., Tan, W., He, J., & Zheng, J. H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.050 · Cited by 37
Self-citationZhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 37
Guha, D., Banerjee, A., Mukherjee, R., Pradhan, B., Peneva, M., Aleksandrov, G., Suklabaidya, S., Senapati, S., & Aich, P. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.03.030 · Cited by 37
Metadata
- Authors
- Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., Choy, H. E., Lee, S. E., Rhee, J. H., & Min, J.-J.
- Affiliations
- Chonnam National University (KR)
- City Of Hope National Medical Center (US)
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Rhee, Joon Haeng
- Min, Jung-Joon
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-02-08
- Volume
- 9
- Issue
- 376
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2586223583
- Cited by
- 588
- References
- 54
- Citations by year
- 2026: 76 · 2025: 81 · 2024: 85 · 2023: 73 · 2022: 71 · 2021: 65 · 2020: 55 · 2019: 34 · 2018: 30 · 2017: 18
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- Funders
- Pioneer Research Center Program (2015M3C1A3056410)
- Bio & Medical Technology Development Program (NRF-2014M3A9B5073747)
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
- NRF (2012-0006072)
- Ministry of Health and Welfare, Republic of Korea (HI14C0187)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer immunotherapy, Salmonella typhimurium, tumor-targeting bacteria, intratumoral macrophages, M1 macrophage polarization, TLR ligands
- MeSH terms
- Animals, Colonic Neoplasms, Flagellin, Genetic Engineering, Humans, Immunotherapy, Macrophages, Male, Mice, Inbred C57BL, Mice, Nude, Neoplasm Metastasis, Neoplasms, Phenotype, Salmonella typhimurium, Colony Count, Microbial, Signal Transduction, Cell Polarity, Xenograft Model Antitumor Assays, HCT116 Cells, Toll-Like Receptor 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.